Aurobindo to expand product basket; eyes $3bn revenues by FY18

Last Updated: Sunday, August 23, 2015, 11:04

The company has several levers to gain traction with a robust business model, a large differentiated product portfolio that addresses six key therapeutic areas and a growing presence in over 150 countries.

Aurobindo Pharma CEO Arvind Vasudeva resigns

Last Updated: Wednesday, July 1, 2015, 17:09

Recently, the drug firm had said that it intends to invest up to Rs 900 crore this fiscal on various activities including capacity expansion, clinical trials and product filings.

Aurobindo gets USFDA nod to sell antibiotic oral suspension

Last Updated: Wednesday, April 15, 2015, 13:04

The approval by the USFDA is for strengths of 100 mg/5 ml and 200 mg/5 ml and the product is ready for launch, Aurobindo Pharma said in a statement.

Aurobindo divests Australian arm to Eris Pharma

Last Updated: Friday, April 10, 2015, 13:23

Aurobindo Pharma has divested stake in its Australian subsidiary to Eris Pharma for an undisclosed amount to focus on the US, European and emerging markets.

Plethico shares soar 20% on settlement pact with Aurobindo

Last Updated: Thursday, April 9, 2015, 20:03

Shares of Plethico Pharmaceuticals zoomed 20 percent Thursday after reaching settlement with Aurobindo Pharma related to the acquisition of US-based Natrol.

Aurobindo gets USFDA nod for Atracurium Besylate injections

Last Updated: Thursday, April 9, 2015, 14:12

Drug major Aurobindo Pharma has received final approval from the US health regulator to manufacture and market Atracurium Besylate injections in the American market.

Plethico to pay Aurobindo Pharma $23.3 mn to settle dispute

Last Updated: Thursday, April 9, 2015, 13:24

Aurobindo Pharma on Thursday said Plethico will pay it USD 23.3 million to settle a dispute related to the acquisition of US-based Natrol.

CCEA clears Glenmark, Aurobindo proposals worth Rs 4,187 cr

Last Updated: Tuesday, April 7, 2015, 21:49

Pharmaceutical majors Glenmark and Aurobindo's foreign investment proposals, worth Rs 4,187 crore, were approved by the government Tuesday.

Aurobindo gets tentative nod from USFDA for Lacosamide tablets

Last Updated: Thursday, March 19, 2015, 17:32

Drug firm Aurobindo Pharma has received tentative approval from the US health regulator USFDA for its generic Lacosamide tablets used in treatment of partial seizures in epilepsy patients.

Cos raise over $4-bn from QIP in FY15; $3-bn more in pipeline

Last Updated: Sunday, March 8, 2015, 12:03

Indian companies have raised over USD 4 billion (Rs 27,000 crore) from Qualified Institutional Placement (QIP) of shares so far in the current fiscal, while plans are underway to garner further funds worth an estimated USD 3 billion through this route.

FIPB refers Rs 4,197 cr Glenmark, Aurobindo proposals to CCEA

Last Updated: Thursday, February 19, 2015, 21:15

The Finance Ministry Thursday referred the foreign investment proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.

FDI proposals worth Rs 1,075.91 cr cleared; Glenmark, Aurobindo sent to CCEA

Last Updated: Thursday, February 19, 2015, 21:13

FIPB has cleared foreign investment in 11 entities, entailing Rs 1,075.91 crore, and referred proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.